Michael Muenzberg, Physician at Comparative Outcomes Group
Comparative Outcomes Group Logo

Michael Muenzberg


Physician
Comparative Outcomes Group
Biosimilars Commercialisation Summit Agenda 2019

Biosimilars Commercialisation Summit Agenda 2019

View Content

Speaker Spotlight- Michael Muenzberg, MD, on the good, the bad and the ugly of the biosimilars market

Speaker Spotlight- Michael Muenzberg, MD, on the good, the bad and the ugly of the biosimilars market

View Content

Conference Day One

Wednesday, February 5th, 2020


10:10 AM Panel Discussion: Exploring the Sensitivity and Complexity of the North American Biosimilars Market


  • Overcome the current battle to combat misinformation surrounding biosimilars in the US, and the essential methods to boost stakeholder confidence, in the face of immense competition from biologics
  • Discuss the current regulatory landscape with respect to the FDA Biosimilar Action Plan and the newly published regulatory framework  regarding  the use of  real world evidence and real world data
  • Explore the game-changing concept of the ‘Purple Book’ for pharmacists, asking “Does this make either medical or commercial logic?”

Conference Day Two

Thursday, March 5th, 2020


4:10 PM Fire-Side Chat: Objection Handling Q&A

  • Confront trials by engaging with a physician to explore how manufacturers and regulators hope to maintain the trust of the public in a relatively novel class of medicines, faced with such potential for future variability, mistrust and misinformation
  • Explore how the risks of  extrapolation of indications can be minimised and the significance of this practice for the biosimilar industry
  • Bring your own challenges to the forefront of the industry and discuss how to tackle prescriber objections 

Check out the incredible speaker line-up to see who will be joining Michael.

Download The Latest Agenda